EDQM: Supplement 11.3 to the European Pharmacopoeia available
Recommendation
Thursday, 29 October 2026 9 .00 - 14.00 h
Practical Approaches for Assessing the Risks of Impurities
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
Supplement 11.3 to the European Pharmacopoeia (Ph.Eur.) is now available and will be implemented on 1 January 2024. According to the EDQM timetable, this supplement will be followed by versions 11.4 to 11.8, with the final implementation date planned for July 2025. The 12th edition of the European Pharmacopoeia (Ph.Eur.) will then be published in July 2025 and enter into force in January 2026. The schedule for the implementation and publication of the individual versions and supplements can be found on the EDQM website.
The EDQM also offers the opportunity to register for the upcoming supplements and to participate in the new versions as an "observer". For further information, please refer to the news section of the 11th European Pharmacopoeia.
We reported on the currently implemented Supplement 11.2 to the European Pharmacopoeia (Ph.Eur.) and the resulting requirements for CEP holders in our news "EDQM: Excipient monographs" and "EDQM: Supplement 11.2 of the European Pharmacopoeia available".
Related GMP News
26.10.2026EMA and CMDh Expand List of Nitrosamine Limits
20.10.2026IPEC Publishes Version 3 of the Excipient Composition Guide
14.10.2026EMA Reports inconsistent Progress in International API Inspection Cooperation
23.09.2026FDA Warning Letter: serious GMP Deficiencies at a Chinese API Manufacturer
16.09.2026PFAS restriction: Commission highlights Importance of critical Medical Applications